Join the Pre-Exposure Prophylaxis group to help and get support from people like you.
Pre-Exposure Prophylaxis News (Page 2)
Related terms: Pre-Exposure Prophylaxis HIV Infection, PrEP, Reducing Risk of HIV Infection
U.S. Foreign Aid Cuts Could Devastate Global Progress Against HIV/AIDS
THURSDAY, March 27, 2025 – HIV could explode worldwide in the wake of U.S. cuts to foreign aid, resulting in millions of AIDS deaths and soaring rates of infection, a new analysis says. President...
Funding Reductions Could Reverse Progress in HIV Response
THURSDAY, March 27, 2025 – Funding reductions could reverse progress in the HIV response by 2030, with the greatest effects anticipated in countries with a higher percentage of international funding...
Trump Administration May Cut CDC's HIV Prevention Division
THURSDAY, March 20, 2025 – The Trump administration is weighing elimination of the U.S. Centers for Disease Control and Prevention’s (CDC) Division on HIV Prevention, sparking concerns among public h...
Federal Judge Rules FDA, CDC Must Restore Health Websites Removed Under Trump Order
TUESDAY, Feb. 12, 2025 – A federal judge has ordered the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) to restore access to public health websites that...
UNAIDS Warns HIV Infections Could Skyrocket Without U.S. Funding
MONDAY, Feb. 10, 2025 – The head of the United Nations AIDS agency (UNAIDS) is warning that a major spike in HIV infections and deaths could occur if the U.S. follows through on freezing foreign aid...
Key CDC Health Websites Vanish Following Trump Orders
MONDAY, Feb. 3, 2025 – The U.S. Centers for Disease Control and Prevention (CDC) has taken down multiple health-related websites and datasets, including those on HIV, LGBTQ health and more,...
Trump Administration Waives Halt on Distribution of HIV Medications Via PEPFAR
WEDNESDAY, Jan. 29, 2025 – The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via the U.S. President's Emergency Plan for AIDS Relief...
Trump Pauses Disbursement of Global HIV Treatment Funds
MONDAY, Jan. 27, 2025 – The Trump administration has paused funding for a crucial HIV treatment program in Africa and developing countries for 90 days, according to a memo obtained by The New York...
Recommendations Provided for Treating, Preventing HIV
FRIDAY, Dec. 27, 2024 – In a special communication issued by the International Antiviral Society-USA Panel and published online Dec. 1 in the Journal of the American Medical Association, the latest...
Twice-Yearly Injection 96% Effective in Preventing HIV Infection
THURSDAY, Nov. 28, 2024 – People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themselves. But researchers have come up with a way to avoid...
Federal Judge Rules That U.S. Military Cannot Reject HIV-Positive Enlistees
FRIDAY, Aug. 23, 2024 – People with HIV can no longer be turned away if they try to enlist in the U.S. military, a federal judge has ruled. The decision, issued this week by U.S. District Judge...
FDA Approves Apretude (cabotegravir extended-release injectable suspension) for HIV Pre-Exposure Prophylaxis (PrEP)
LONDON--(BUSINESS WIRE) December 20, 2021 --ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi Limited (Shionogi)...
FDA Approves Descovy (emtricitabine and tenofovir alafenamide) for HIV Pre-Exposure Prophylaxis (PrEP)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct. 3, 2019-- Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug Administration (FDA) approved a pre-exposure prophylaxis (PrEP) in...
FDA Approves Expanded Indication for Truvada (emtricitabine and tenofovir disoproxil fumarate) for Reducing the Risk of Acquiring HIV-1 in Adolescents
FOSTER CITY, Calif.--(BUSINESS WIRE)--May 15, 2018-- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Truvada...